Aurobindo Pharma declines despite reporting 23% rise in Q1 consolidated net profit

13 Aug 2020 Evaluate

Aurobindo Pharma is currently trading at Rs. 896.40, down by 37.60 points or 4.03% from its previous closing of Rs. 934.00 on the BSE.

The scrip opened at Rs. 934.00 and has touched a high and low of Rs. 934.00 and Rs. 891.10 respectively. So far 434381 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 967.60 on 10-Aug-2020 and a 52 week low of Rs. 281.15 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 967.60 and Rs. 891.10 respectively. The current market cap of the company is Rs. 52503.03 crore.

The promoters holding in the company stood at 52.01%, while Institutions and Non-Institutions held 35.19% and 12.80% respectively.

Aurobindo Pharma has reported over 2-fold jump in its net profit at Rs 714.68 crore for the quarter ended June 30, 2020 as compared to Rs 330.50 crore for the same quarter in the previous year. Total income of the company increased by 14.03% at Rs 3,545.28 crore for Q1FY21 as compared Rs 3,108.97 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 22.77% in its net profit attributed to owner at Rs 780.58 crore for the quarter ended June 30, 2020 as compared to Rs 635.83 crore for the same quarter in the previous year. Total income of the company increased by 10.62% at Rs 6,040.37 crore for Q1FY21 as compared Rs 5,460.38 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1114.90 5.10 (0.46%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.80
Dr. Reddys Lab 5959.10
Cipla 1352.95
Zydus Lifesciences 934.50
Lupin 1599.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.